Key lipid changes with GLP-1 receptor agonists include: Triglycerides: 15-25% reduction Total cholesterol: 3-8% reduction LDL cholesterol: 3-7% reduction HDL cholesterol: 2-5% increase Non-HDL cholesterol: 5-10% reduction The SELECT cardiovascular outcomes trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease who were receiving standard background care
Build on the Habits Youve Developed During treatment, your reduced appetite naturally led to smaller portions and fewer cravings
[DOI] [PubMed] [Google Scholar] [101].Powell DR, Smith M, Greer J, Harris A, Zhao S, DaCosta C, Mseeh F, Shadoan MK, Sands A, Zambrowicz B, Ding Z-M, Journal of Pharmacology and Experimental Therapeutics 2013, 345, 250
You did not provide enough medical evidence
helpful for constipation
Surgery: Indicated for complete structural tears but involves prolonged recovery, scar tissue formation, and variable long-term outcomes in chronic cases